Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial

被引：0
|
作者：
Ki Wook Yun
Hoan Jong Lee
Jin Han Kang
Byung Wook Eun
Yae-Jean Kim
Kyung-Hyo Kim
Nam Hee Kim
Young Jin Hong
Dong Ho Kim
Hwang Min Kim
Sung-Ho Cha
机构：
[1] Seoul National University College of Medicine,Department of Pediatrics
[2] Chung-Ang University College of Medicine,Department of Pediatrics
[3] The Catholic University of Korea,Department of Pediatrics, College of Medicine
[4] Eulji University School of Medicine,Department of Pediatrics, Eulji General Hospital
[5] Sungkyunkwan University School of Medicine,Departments of Pediatrics, Samsung Medical Center
[6] Ewha Womans University,Department of Pediatrics, School of Medicine
[7] Inje University College of Medicine,Department of Pediatrics, Ilsan Paik Hospital
[8] Inha University College of Medicine,Department of Pediatrics
[9] Korea Cancer Center Hospital,Department of Pediatrics
[10] Yonsei University Wonju College of Medicine,Department of Pediatrics
[11] Kyunghee University,Department of Pediatrics, College of Medicine
来源：
BMC Infectious Diseases | / 15卷
关键词：
Japanese encephalitis; Vaccine; Vero cells; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 21 条
  • [1] Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial
    Yun, Ki Wook
    Lee, Hoan Jong
    Kang, Jin Han
    Eun, Byung Wook
    Kim, Yae-Jean
    Kim, Kyung-Hyo
    Kim, Nam Hee
    Hong, Young Jin
    Kim, Dong Ho
    Kim, Hwang Min
    Cha, Sung-Ho
    BMC INFECTIOUS DISEASES, 2015, 15
  • [2] Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)
    Kikukawa, Akiko
    Gomi, Yasuyuki
    Akechi, Masateru
    Onishi, Toshiyuki
    Manabe, Sadao
    Namazue, Junko
    Fuke, Isao
    Ishikawa, Toyokazu
    Okuno, Yoshinobu
    Ueda, Shigeharu
    VACCINE, 2012, 30 (13) : 2329 - 2335
  • [3] Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children
    Okada, Kenji
    Iwasa, Toshiaki
    Namazue, Junko
    Akechi, Masateru
    Ueda, Shigeharu
    VACCINE, 2012, 30 (41) : 5967 - 5972
  • [4] Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine
    Yun, Ki Wook
    Lee, Hoan Jong
    Park, Ji Young
    Cho, Hye-Kyung
    Kim, Yae-Jean
    Kim, Kyung-Hyo
    Kim, Nam Hee
    Hong, Young Jin
    Kim, Dong Ho
    Kim, Hwang Min
    Cha, Sung-Ho
    VACCINE, 2018, 36 (11) : 1398 - 1404
  • [5] Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
    Chanthavanich, Pornthep
    Limkittikul, Kriengsak
    Sirivichayakul, Chukiat
    Chokejindachai, Watcharee
    Hattasingh, Weerawan
    Pengsaa, Krisana
    Surangsrirat, Surachai
    Srisuwannaporn, Termsang
    Kaewma, Benjawan
    Yoksan, Sutee
    Jun, Gao
    Zhumu, Bai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 900 - 905
  • [6] Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
    Woolpert, Tabitha
    Staples, J. Erin
    Faix, Dennis J.
    Nett, Randall J.
    Kosoy, Olga I.
    Biggerstaff, Brad J.
    Johnson, Barbara W.
    Sracic, Michael
    Fischer, Marc
    VACCINE, 2012, 30 (20) : 3090 - 3096
  • [7] Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
    Tauber, E.
    Kollaritsch, H.
    Korinek, M.
    Rendi-Wagner, P.
    Jilma, B.
    Firbas, C.
    Schranz, S.
    Jong, E.
    Klingler, A.
    Dewasthaly, S.
    Klade, C. S.
    LANCET, 2007, 370 (9602): : 1847 - 1853
  • [8] Immunogenicity and safety of Vero cell culture-derived Japanese encephalitis vaccine: a phase 3 study in Chinese infants
    Wang, Huanhuan
    Wang, Juan
    Yan, Shijie
    Zhao, Gengfan
    Wang, Shanzhen
    Tao, Hong
    Xu, Ye
    Wu, Jinfeng
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 958 - 965
  • [9] Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain
    Miyazaki, Chiaki
    Okada, Kenji
    Ozaki, Takao
    Hirose, Mizuo
    Iribe, Kaneshige
    Yokote, Hiroyuki
    Ishikawa, Yuji
    Togashi, Takehiro
    Ueda, Kohji
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (02) : 188 - 195
  • [10] A novel, vero cell derived, purified, inactivated Japanese encephalitis virus vaccine: Results of a randomized controlled phase 3 trial
    Tauber, Erich
    Kollaritsch, Herwig
    Korinek, Maria
    Rendi-Wagner, Pamela
    Jilma, Bernd
    Firbas, Christa
    Schranz, Sabine
    Jong, Elaine
    Klingler, Anton
    Klade, Christoph
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 283 - 283
123